184 related articles for article (PubMed ID: 1156454)
1. Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis. A prospective study.
Athreya BH; Moser G; Cecil HS; Myers AR
Arthritis Rheum; 1975; 18(4):347-52. PubMed ID: 1156454
[TBL] [Abstract][Full Text] [Related]
2. Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis.
Bernstein BH; Singsen BH; King KK; Hanson V
Am J Dis Child; 1977 Jun; 131(6):659-63. PubMed ID: 868818
[TBL] [Abstract][Full Text] [Related]
3. Correlations between transaminase concentrations and serum salicylate concentration in juvenile rheumatoid arthritis.
Miller JJ; Weissman DB
Arthritis Rheum; 1976; 19(1):115-8. PubMed ID: 1252262
[TBL] [Abstract][Full Text] [Related]
4. Serum transaminases during salicylate therapy.
Russell AS; Sturge RA; Smith MA
Br Med J; 1971 May; 2(5759):428-9. PubMed ID: 5576002
[TBL] [Abstract][Full Text] [Related]
5. Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis.
Rich RR; Johnson JS
Arthritis Rheum; 1973; 16(1):1-9. PubMed ID: 4692157
[No Abstract] [Full Text] [Related]
6. Aspirin-induced abnormalities of liver function.
Athreya BH; Gorske AL; Myers AR
Am J Dis Child; 1973 Nov; 126(5):638-41. PubMed ID: 4745155
[No Abstract] [Full Text] [Related]
7. Aspirin in the treatment of juvenile arthritis.
Baum J
Am J Med; 1983 Jun; 74(6A):10-5. PubMed ID: 6344620
[TBL] [Abstract][Full Text] [Related]
8. Salicylate therapy in juvenile rheumatoid arthritis. Dose, serum level, and toxicity.
Doughty RA; Giesecke L; Athreya B
Am J Dis Child; 1980 May; 134(5):461-3. PubMed ID: 7377152
[TBL] [Abstract][Full Text] [Related]
9. Salicylate hepatotoxicity.
Koppes GM; Arnett FC
Postgrad Med; 1974 Oct; 56(4):193-5. PubMed ID: 4415672
[No Abstract] [Full Text] [Related]
10. Chronic salicylate administration in juvenile rheumatoid arthritis: aspirin "hepatitis" and its clinical significance.
Schaller JG
Pediatrics; 1978 Nov; 62(5 Pt 2 Suppl):916-25. PubMed ID: 724343
[TBL] [Abstract][Full Text] [Related]
11. Serum enzyme abnormalities in juvenile rheumatoid arthritis.
Rachelefsky GS; Kar NC; Coulson A; Sarkissian E; Stiehm ER; Paulus HE
Pediatrics; 1976 Nov; 58(5):730-6. PubMed ID: 980605
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of salicylate-induced liver damage.
Levy G; Yaffe SJ
Am J Dis Child; 1975 Dec; 129(12):1385-6. PubMed ID: 1199979
[No Abstract] [Full Text] [Related]
13. [Salicylate induced disturbances of liver function (author's transl)].
von Mühlendahl KE
Dtsch Med Wochenschr; 1982 Jan; 107(3):101-3. PubMed ID: 7056156
[No Abstract] [Full Text] [Related]
14. [Serum enzymes for the diagnosis of experimental acute hepatic necrosis].
Chalifoux A; Lagacé A
Can J Comp Med; 1969 Jul; 33(3):178-86. PubMed ID: 4242768
[TBL] [Abstract][Full Text] [Related]
15. Salicylate-induced consumption coagulopathy.
Pinedo HM; van de Putte LB; Loeliger EA
Ann Rheum Dis; 1973 Jan; 32(1):66-8. PubMed ID: 4685881
[No Abstract] [Full Text] [Related]
16. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis.
Fries JF; Singh G; Lenert L; Furst DE
Arthritis Rheum; 1990 Nov; 33(11):1611-9. PubMed ID: 2242059
[TBL] [Abstract][Full Text] [Related]
17. Chronic salicylism in a patient with juvenile rheumatoid arthritis.
Everson GW; Krenzelok EP
Clin Pharm; 1986 Apr; 5(4):334-41. PubMed ID: 3709082
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of liver disease in patients taking salicylates for arthropathy.
Carneskog J; Florath-Ahlmen M; Olsson R
Hepatogastroenterology; 1980 Oct; 27(5):361-4. PubMed ID: 7203370
[TBL] [Abstract][Full Text] [Related]
19. Aspirin hepatotoxicity and disseminated intravascular coagulation.
Sbarbaro JA; Bennett RM
Ann Intern Med; 1977 Feb; 86(2):183-5. PubMed ID: 835940
[TBL] [Abstract][Full Text] [Related]
20. The impact of total parenteral nutrition on liver function tests in patients with cancer.
Wagman LD; Burt ME; Brennan MF
Cancer; 1982 Mar; 49(6):1249-57. PubMed ID: 6800631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
